Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Roferon (rIFN-α 2a ) Is More Immunogenic Than Intron A (rIFN-α 2b ) in Patients with Chronic Myelogenous Leukemia